Have a feature idea you'd love to see implemented?
Let us know!
INBX Inhibrx Biosciences Inc.
Price (delayed)
$13.98
Market cap
$202.37M
P/E Ratio
N/A
Dividend/share
N/A
EPS
N/A
Enterprise value
$7.88M
Highlights
The debt has contracted by 15% from the previous quarter
The quick ratio has contracted by 23% from the previous quarter
Inhibrx Biosciences's equity has decreased by 19% QoQ
Key stats
What are the main financial stats of INBX
Market
Valuations
Earnings
Shares outstanding
14.48M
Market cap
$202.37M
Enterprise value
$7.88M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.13
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
N/A
EBIT
N/A
EBITDA
N/A
Free cash flow
N/A
Per share
Balance sheet
Liquidity
EPS
N/A
Free cash flow per share
N/A
Book value per share
$12.33
Revenue per share
N/A
TBVPS
$14.39
Total assets
$222.56M
Total liabilities
$44.1M
Debt
$1.84M
Equity
$178.47M
Working capital
$163.35M
Debt to equity
0.01
Current ratio
4.7
Quick ratio
4.48
Net debt/EBITDA
N/A
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
N/A
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INBX stock price
How has the Inhibrx Biosciences stock price performed over time
Intraday
-0.43%
1 week
-2.44%
1 month
-9.81%
1 year
N/A
YTD
N/A
QTD
-10.73%
Financial performance
How have Inhibrx Biosciences's revenue and profit performed over time
Revenue
N/A
Gross profit
N/A
Operating income
N/A
Net income
N/A
Gross margin
N/A
Net margin
N/A
Growth
What is Inhibrx Biosciences's growth rate over time
Valuation
What is Inhibrx Biosciences stock price valuation
P/E
N/A
P/B
1.13
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Inhibrx Biosciences's equity has decreased by 19% QoQ
Efficiency
How efficient is Inhibrx Biosciences business performance
Dividends
What is INBX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INBX.
Financial health
How did Inhibrx Biosciences financials performed over time
The current ratio has declined by 24% since the previous quarter
The quick ratio has contracted by 23% from the previous quarter
The debt is 99% less than the equity
Inhibrx Biosciences's equity has decreased by 19% QoQ
The debt has contracted by 15% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.